Decremental Exercise: a New Training Approach?

March 17, 2020 updated by: Swiss Federal Institute of Technology

Decremental Exercise Protocol as a Training Stimulus: More or Less Efficient Than Traditional High-intensity Interval Training?

Different types of high-intensity interval training (HIIT) sessions are used by athletes in order to improve their physical performance, but innovative approaches to training are lacking. Therefore, in Part A of this study the physiological response to a standard HIIT and a new decremental exercise training (DECT) will be compared in runners and cyclists. Next, in Part B the training effects of a 4-week block of the HIIT and DECT will be compared.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • ZH
      • Zurich, ZH, Switzerland, 8057
        • Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: 18-40 years
  • Healthy, i.e. normal physical and mental status (not taking any medication on a regular basis for more than a month, except contraceptive medication)
  • Normal Body-Mass-Index (BMI): 18.5-24.9 kg·m-2
  • Well-trained athletes: V̇O2max > 55.1 ml·min-1·kg-1 for men and > 50.1 ml·min-1·kg-1 for women
  • Normal lung function
  • Non-smoking
  • Willing to adhere to the general study rules

Exclusion Criteria:

  • Women who are pregnant or breast feeding
  • Intention to become pregnant during the course of the study
  • Known or suspected non-compliance, drug or alcohol abuse
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Previous enrolment into the same part (A or B) of the current study
  • Enrolment of the investigator, his/her family members, employees and other dependent persons
  • Acute or chronic illness
  • Intake of medications affecting performance or the respiratory, cardiovascular or neuromuscular system
  • Insufficient training history (<3 yrs of participation in competitive cycling/running) or training volume (<40 km running/week or 150 km cycling/week) in the previous 6 months
  • Recent (<3 months) history of orthopaedic injury or participation in structured high-intensity training blocks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: DECT Group
The DECT session consists of four bouts of 4 min high-intensity "decremental" exercise with 3 min of active recovery between bouts. Load is progressively decreased throughout each exercise bout. The training period will last for a total of 4 weeks, with three weekly sessions of supervised training
The DECT program consists of a 4-week training intervention with three weekly sessions of high-intensity interval training, in which during each exercise bout the workload is imposed in a decremental fashion.
Active Comparator: HIIT Group
The HIIT session consists of four bouts of 4 min high-intensity "decremental" exercise with 3 min of active recovery between bouts. Load is kept constant throughout each exercise bout. The training period will last for a total of 4 weeks, with three weekly sessions of supervised training
The HIIT program consists of a 4-week training intervention with three weekly sessions of high-intensity interval training, in which during each exercise bout the workload is kept constant.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in exercise performance
Time Frame: measured before and after the 4-week training block, during a time-trial (40 km cycling or 10 km running)
Time taken to cover a fixed distance, in minutes
measured before and after the 4-week training block, during a time-trial (40 km cycling or 10 km running)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in maximal oxygen uptake
Time Frame: Measured during a maximal incremental exercise test before and after the 4-week training block
Measured in ml/kg/min
Measured during a maximal incremental exercise test before and after the 4-week training block
Average oxygen uptake
Time Frame: The two training session are performed within one week
Average oxygen uptake measured during the four 4-min bouts of high-intensity exercise of a session of HIIT and DECT
The two training session are performed within one week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christina M Spengler, Prof., ETH Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2017

Primary Completion (Actual)

December 11, 2019

Study Completion (Actual)

December 11, 2019

Study Registration Dates

First Submitted

May 12, 2017

First Submitted That Met QC Criteria

May 15, 2017

First Posted (Actual)

May 16, 2017

Study Record Updates

Last Update Posted (Actual)

March 18, 2020

Last Update Submitted That Met QC Criteria

March 17, 2020

Last Verified

February 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • DECT_HIIT_2017

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise Performance of Fit Athletes

Clinical Trials on DECT

3
Subscribe